Document is current

Article History

Received: 13 September 2022

Accepted: 1 February 2023

First Online: 24 February 2023

Declarations

:

: This study was sponsored by Ivory Dentin Graft Ltd., Tel Aviv, Israel. Dr Sapoznikov is owner and employee of Ivory Dentin Graft Ltd. which is developing Ivory Dentin Graft for the market. Dr. Scortecci is a minority shareholder in Ivory Dentin Graft Ltd. Martin Humphrey is an independent consultant to Ivory Dentin Graft Ltd. Drs. Haim and Zavan report no conflicts of interest related to this study.

: The protocol was in accordance with the Helsinki Declaration and the Fortaleza revisions, ICH E6 (R2), and ISO 14155:2011 and was approved by the Institutional Review Board for Clinical Research at Asaf Harofeh Medical Center (Approval No. 0102–17-ASF) and the Israeli Ministry of Health (approval no. 20173907). Written informed consents were obtained from all participants after the provision of a detailed explanation of the protocol and the benefits or risks of participation.

: Dr. Sapoznikov is the owner and employee of Ivory Dentin Graft Ltd. which is developing Ivory Dentin Graft for the market. Dr. Scortecci is a minority shareholder in Ivory Dentin Graft Ltd. Martin Humphrey is an independent consultant to Ivory Dentin Graft Ltd. Drs. Haim and Zavan report no conflicts of interest related to this study.